By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Aridis Pharmaceuticals 

5941 Optical Court

San Jose  California  95138  U.S.A.
Phone: 408-385-1742 Fax: 408-960-3822




Company News
Aridis Pharma Presents Positive Phase IIa Safety And Efficacy Data Of Salvecin (AR-301) In Patients With Severe Pneumonia Caused By Staphylococcus Aureus During The 2017 ASM Microbe Congress 6/5/2017 8:27:32 AM
Aridis Pharma Reports Positive Clinical Data From Phase 1/2a Study Of Human Monoclonal Antibody AR-301 For Treating Pneumonia 1/6/2017 6:22:08 AM
Aridis Pharmaceuticals Expands The Company's Clinical Advisory Board; Adds Three Industry Veterans With Unique Expertise In The Field 7/11/2016 6:33:59 AM
Aridis Pharmaceuticals Strengthens Board Of Directors With Former Wyeth (WYE) (Now Pfizer (PFE) President Of R&D Robert Ruffolo, Jr. 4/18/2016 10:12:05 AM
Aridis Pharmaceuticals Expands Patent Portfolio For Several Fully Human Monoclonal Antibodies Against Infectious Disease Targets 2/24/2016 7:03:17 AM
Aridis Pharmaceuticals To Present At BIO CEO & Investor Conference 2016 2/2/2016 9:05:51 AM
Aridis Pharmaceuticals Reports Positive Phase 1 Clinical Results For Aerucin For Treating Hospital-Acquired And Ventilator-Associated Pneumonia 1/7/2016 6:45:55 AM
Aridis Pharmaceuticals To Present At Biotech Showcase 2016 1/6/2016 11:08:40 AM
Aridis Pharmaceuticals Receives Multiple NIH Grants 10/13/2015 6:33:23 AM
Aridis Pharmaceuticals Receives FDA Fast Track Designation For AR-301 For Acute Pneumonia Caused By Staphylococcus Aureus 9/11/2015 6:52:03 AM